Compare NBTX & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | TPB |
|---|---|---|
| Founded | 2003 | 1988 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Tobacco |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2018 | 2015 |
| Metric | NBTX | TPB |
|---|---|---|
| Price | $38.05 | $87.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $36.00 | ★ $115.00 |
| AVG Volume (30 Days) | 119.2K | ★ 362.1K |
| Earning Date | 03-31-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | N/A | ★ 45.33 |
| EPS | N/A | ★ 3.11 |
| Revenue | N/A | ★ $463,062,000.00 |
| Revenue This Year | $58.17 | $13.68 |
| Revenue Next Year | N/A | $11.32 |
| P/E Ratio | ★ N/A | $27.77 |
| Revenue Growth | N/A | ★ 28.39 |
| 52 Week Low | $8.03 | $65.80 |
| 52 Week High | $57.14 | $146.90 |
| Indicator | NBTX | TPB |
|---|---|---|
| Relative Strength Index (RSI) | 49.41 | 57.48 |
| Support Level | $34.83 | $86.79 |
| Resistance Level | $41.99 | $92.31 |
| Average True Range (ATR) | 1.99 | 3.99 |
| MACD | -0.09 | 0.93 |
| Stochastic Oscillator | 51.22 | 73.16 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.